The microbiome stimulates protumorigenic IL32 expression in multiple myeloma (MM) cells via TLRs-NFkB (105), and Treg-derived IL32 promotes bladder cancer metastasis and immunosuppression together with TIGIT (106). The gene discussed is IL32; the disease is urinary bladder cancer.